home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Autoimmune Advance

  April, 20 2002 1:07
your information resource in human molecular genetics
Advances in understanding what stimulates autoantibodies to form and destroy tissues in lupus, rheumatoid arthritis and other systemic autoimmune diseases are announced in Nature (Vol. 416, No. 6881, dated 11 April 2002). The findings should open new avenues for treatment.

Ann Marshak Rothstein of Boston University School of Medicine, Massachusetts, and colleagues reveal an unexpected mechanism that explains how immune cells might perceive antibodies as pathogens, provoking the production of autoantibodies. They show that activation of autoreactive B cells involves the co-engagement of the B-cell receptor and a Toll-like receptor (TLR9) by antibody/autoantigen immune complexes. This establishes that endogenous TLR ligands have a critical role in the aberrant activation of the adaptive immune system.

"This raises the possibility that the drug chloroquine, which inhibits TLR9-mediated signalling, may be effective in some patients with systemic autoimmune diseases," explain Carola G. Vinuesa and Christopher C. Goodnow of the Australian National University, Canberra, in an accompanying News and Views article. "Drugs that specifically target Toll-like-receptor signalling pathways could be promising new treatments for antibody-mediated autoimmune diseases or their complications," they conclude.


Ann Marshak Rothstein
tel +1 617 638 4299
e-mail amrothst@bu.edu

Christopher C. Goodnow
tel +61 2 6125 3621
e-mail chris.goodnow@anu.edu.au

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.